Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials
José Antônio Marin Neto
American Heart Journal St. Louis v. 148, n. 1, p. 52-61, 2004St. Louis 2004
Localização: FMRP - Fac. Medicina de Ribeirão Preto (pcd 1400480 )(Acessar)
- 0
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
pcd 1400857
pcd 1399576@1
browse_callnumber
display.do?vl(4708289UI0)=creator&gathStatTab=true&dscnt=0&callNumberBrowseField=browse_callnumber&mode=Basic&tabRealType=browseshelf&vid=USP&rfnGrp=1&tab=default_tab&vl(56004861UI1)=all_items&dstmp=1717144076844&rfnGrpCounter=1&scp.scps=scope%3A%28USP_VIDEOS%29%2Cscope%3A%28%22PRIMO%22%29%2Cscope%3A%28USP_FISICO%29%2Cscope%3A%28USP_EREVISTAS%29%2Cscope%3A%28USP%29%2Cscope%3A%28USP_EBOOKS%29%2Cscope%3A%28USP_PRODUCAO%29%2Cprimo_central_multiple_fe&fctV=%5B2004+TO+2013%5D&callNumber=pcd+1400480&fctN=facet_creationdate&vl(freeText0)=Marin%20Neto%2C%20J&ct=display&fn=search&indx=4&recIdxs=0&elementId=0
Página Inicial
RSS
Feed
Políticas
Fale Conosco-
Realização:
Logos de Redes Sociais: 